Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Amdizalisib by Hutchison MediPharma for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma): Likelihood of Approval
Amdizalisib is under clinical development by Hutchison MediPharma and currently in Phase I for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated...
Amdizalisib by Hutchison MediPharma for Nodal Marginal Zone B-Cell Lymphoma: Likelihood of Approval
Amdizalisib is under clinical development by Hutchison MediPharma and currently in Phase I for Nodal Marginal Zone B-Cell Lymphoma. According...
Amdizalisib by Hutchison MediPharma for Splenic Marginal Zone B-Cell Lymphoma: Likelihood of Approval
Amdizalisib is under clinical development by Hutchison MediPharma and currently in Phase I for Splenic Marginal Zone B-Cell Lymphoma. According...